For Clinicians
AT Testing
Send a sample for AT testing
AT Mutation Testing Populations
Necessity of testing to be determined by the referring physician for the diagnosis of ATM. Assay offered is AT protein evaluation.
We use our unique microRNA-based biomarkers to personalize cancer treatments and drug development.
Information
- Privacy Policy
- Financial Conflict of Interest Policy
- MiraDX CLIA certification #: 07D2006340
Contact Us
CLIA Lab Address:
Administrative Address: